174 related articles for article (PubMed ID: 11113294)
1. In vivo pharmacology of SDZ 249-665, a novel, non-pungent capsaicin analogue.
Urban L; Campbell EA; Panesar M; Patel S; Chaudhry N; Kane S; Buchheit KH; Sandells B; James IF
Pain; 2000 Dec; 89(1):65-74. PubMed ID: 11113294
[TBL] [Abstract][Full Text] [Related]
2. Anti-nociceptive and desensitizing effects of olvanil on capsaicin-induced thermal hyperalgesia in the rat.
Alsalem M; Millns P; Altarifi A; El-Salem K; Chapman V; Kendall DA
BMC Pharmacol Toxicol; 2016 Jul; 17(1):31. PubMed ID: 27439609
[TBL] [Abstract][Full Text] [Related]
3. Oral anti-hyperalgesic and anti-inflammatory activity of NK(1) receptor antagonists in models of inflammatory hyperalgesia of the guinea-pig.
Campbell EA; Gentry C; Patel S; Kidd B; Cruwys S; Fox AJ; Urban L
Pain; 2000 Sep; 87(3):253-263. PubMed ID: 10963905
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of duloxetine, a potent and balanced serotonergic and noradrenergic reuptake inhibitor, in inflammatory and acute pain models in rodents.
Jones CK; Peters SC; Shannon HE
J Pharmacol Exp Ther; 2005 Feb; 312(2):726-32. PubMed ID: 15494550
[TBL] [Abstract][Full Text] [Related]
5. Palvanil, a non-pungent capsaicin analogue, inhibits inflammatory and neuropathic pain with little effects on bronchopulmonary function and body temperature.
Luongo L; Costa B; D'Agostino B; Guida F; Comelli F; Gatta L; Matteis M; Sullo N; De Petrocellis L; de Novellis V; Maione S; Di Marzo V
Pharmacol Res; 2012 Sep; 66(3):243-50. PubMed ID: 22634607
[TBL] [Abstract][Full Text] [Related]
6. TRPV1 activation and induction of nociceptive response by a non-pungent capsaicin-like compound, capsiate.
Iida T; Moriyama T; Kobata K; Morita A; Murayama N; Hashizume S; Fushiki T; Yazawa S; Watanabe T; Tominaga M
Neuropharmacology; 2003 Jun; 44(7):958-67. PubMed ID: 12726827
[TBL] [Abstract][Full Text] [Related]
7. Antinociceptive activity of ricinoleic acid, a capsaicin-like compound devoid of pungent properties.
Vieira C; Evangelista S; Cirillo R; Terracciano R; Lippi A; Maggi CA; Manzini S
Eur J Pharmacol; 2000 Oct; 407(1-2):109-16. PubMed ID: 11050297
[TBL] [Abstract][Full Text] [Related]
8. Capsazepine reversal of the antinociceptive action of capsaicin in vivo.
Perkins MN; Campbell EA
Br J Pharmacol; 1992 Oct; 107(2):329-33. PubMed ID: 1422585
[TBL] [Abstract][Full Text] [Related]
9. Antinociceptive profile of the pseudopeptide B2 bradykinin receptor antagonist NPC 18688 in mice.
Corrêa CR; Kyle DJ; Chakraverty S; Calixto JB
Br J Pharmacol; 1996 Feb; 117(3):552-558. PubMed ID: 8821548
[TBL] [Abstract][Full Text] [Related]
10. Roles of capsaicin-sensitive primary afferents in differential rat models of inflammatory pain: a systematic comparative study in conscious rats.
Chen HS; He X; Wang Y; Wen WW; You HJ; Arendt-Nielsen L
Exp Neurol; 2007 Mar; 204(1):244-51. PubMed ID: 17188267
[TBL] [Abstract][Full Text] [Related]
11. N-palmitoyl-vanillamide (palvanil) is a non-pungent analogue of capsaicin with stronger desensitizing capability against the TRPV1 receptor and anti-hyperalgesic activity.
De Petrocellis L; Guida F; Moriello AS; De Chiaro M; Piscitelli F; de Novellis V; Maione S; Di Marzo V
Pharmacol Res; 2011 Apr; 63(4):294-9. PubMed ID: 21215315
[TBL] [Abstract][Full Text] [Related]
12. The capsaicin analogue SDZ249-665 attenuates the hyper-reflexia and referred hyperalgesia associated with inflammation of the rat urinary bladder.
Jaggar SI; Scott HC; James IF; Rice AS
Pain; 2001 Jan; 89(2-3):229-35. PubMed ID: 11166479
[TBL] [Abstract][Full Text] [Related]
13. State-dependent phosphorylation of epsilon-isozyme of protein kinase C in adult rat dorsal root ganglia after inflammation and nerve injury.
Zhou Y; Li GD; Zhao ZQ
J Neurochem; 2003 May; 85(3):571-80. PubMed ID: 12694383
[TBL] [Abstract][Full Text] [Related]
14. The VR1 antagonist capsazepine reverses mechanical hyperalgesia in models of inflammatory and neuropathic pain.
Walker KM; Urban L; Medhurst SJ; Patel S; Panesar M; Fox AJ; McIntyre P
J Pharmacol Exp Ther; 2003 Jan; 304(1):56-62. PubMed ID: 12490575
[TBL] [Abstract][Full Text] [Related]
15. Antinociceptive and antihyperalgesic effects of tapentadol in animal models of inflammatory pain.
Schiene K; De Vry J; Tzschentke TM
J Pharmacol Exp Ther; 2011 Nov; 339(2):537-44. PubMed ID: 21816956
[TBL] [Abstract][Full Text] [Related]
16. Divergent peripheral effects of pituitary adenylate cyclase-activating polypeptide-38 on nociception in rats and mice.
Sándor K; Bölcskei K; McDougall JJ; Schuelert N; Reglodi D; Elekes K; Petho G; Pintér E; Szolcsányi J; Helyes Z
Pain; 2009 Jan; 141(1-2):143-50. PubMed ID: 19091468
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of selective NK(1) receptor antagonist CI-1021 in animal models of inflammatory and neuropathic pain.
Gonzalez MI; Field MJ; Hughes J; Singh L
J Pharmacol Exp Ther; 2000 Aug; 294(2):444-50. PubMed ID: 10900217
[TBL] [Abstract][Full Text] [Related]
18. A-425619 [1-isoquinolin-5-yl-3-(4-trifluoromethyl-benzyl)-urea], a novel transient receptor potential type V1 receptor antagonist, relieves pathophysiological pain associated with inflammation and tissue injury in rats.
Honore P; Wismer CT; Mikusa J; Zhu CZ; Zhong C; Gauvin DM; Gomtsyan A; El Kouhen R; Lee CH; Marsh K; Sullivan JP; Faltynek CR; Jarvis MF
J Pharmacol Exp Ther; 2005 Jul; 314(1):410-21. PubMed ID: 15837818
[TBL] [Abstract][Full Text] [Related]
19. Analgesic effects of the selective group II (mGlu2/3) metabotropic glutamate receptor agonists LY379268 and LY389795 in persistent and inflammatory pain models after acute and repeated dosing.
Jones CK; Eberle EL; Peters SC; Monn JA; Shannon HE
Neuropharmacology; 2005; 49 Suppl 1():206-18. PubMed ID: 15998527
[TBL] [Abstract][Full Text] [Related]
20. Local administration of mu or kappa opioid agonists attenuates capsaicin-induced thermal hyperalgesia via peripheral opioid receptors in rats.
Ko MC; Tuchman JE; Johnson MD; Wiesenauer K; Woods JH
Psychopharmacology (Berl); 2000 Feb; 148(2):180-5. PubMed ID: 10663433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
